Institutional investors purchased a net $18.6 million shares of AZN during the quarter ended June 2014 and now own 8.21% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APERIO GROUP LLC Bought 15.4 Thousand shares of AstraZeneca PLC
QUANTBOT TECHNOLOGIES LLC Bought 10.1 Thousand shares of AstraZeneca PLC